Mark Hahn

Mark Hahn

Direktor/Vorstandsmitglied bei
Opterion Health AG
63 Jahre
Health Technology
Communications
Technology Services

Profil

Mark W.
Hahn
is currently Chairman at Slate Medicines, Inc. since 2026 and Director at Opterion Health AG since 2025.
Former roles include Independent Director at Soleno Therapeutics, Inc. from 2025 to 2026, Independent Director at ALSP Orchid Acquisition Corp.
I from 2021 to 2023, Chief Financial Officer at Verona Pharma Ltd. from 2020 to 2025, Chief Financial Officer at Dova Pharmaceuticals, Inc. from 2018 to 2019, Chief Financial Officer & Executive Vice President at Cempra Pharmaceuticals, Inc. and Chief Financial Officer at Cempra, Inc. from 2010 to 2017, Chief Financial Officer at Athenix Corp.
from 2008 to 2009, Chief Financial Officer & VP-Administration at Gigabeam Corp.
from 2007 to 2008, Chief Financial Officer at BuildLinks, Inc. from 2002 to 2007, Chief Financial Officer at Charles & Colvard Ltd. from 1984 to 1996, Chief Financial Officer at Equitel, Inc., Principal at Ernst & Young LLP, and Chief Financial Officer at Performaworks, Inc. Education includes an undergraduate degree from the University of Wisconsin-Milwaukee conferred in 1984.

Aktive Positionen von Mark Hahn

UnternehmenPositionBeginn
Direktor/Vorstandsmitglied 01.05.2025

Ehemalige bekannte Positionen von Mark Hahn

UnternehmenPositionEnde
SOLENO THERAPEUTICS, INC. Direktor/Vorstandsmitglied 15.05.2026
VERONA PHARMA PLC Finanzdirektor/CFO 01.10.2025
ALSP ORCHID ACQUISITION CORPORATION I Direktor/Vorstandsmitglied 01.11.2023
DOVA PHARMACEUTICALS, INC. Finanzdirektor/CFO 12.11.2019
Finanzdirektor/CFO 30.11.2017
Sehen Sie sich die Erfahrung von Mark Hahn im Detail an

Ausbildung von Mark Hahn

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

56

Beziehungen ersten Grades

15

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen15

Consumer Durables

Communications

Commercial Services

Process Industries

Communications

Technology Services

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Consumer Services

Health Technology

Health Services

Finance

  1. Börse
  2. Insider
  3. Mark Hahn